RxDoctor Payments Data

Justin Tenney, MD

Otolaryngology · Thibodaux, LANPI 1245448224

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Aerin Medical Inc. at 27.4% of the total. 2025 is the largest year on record at $4,424, 2.4 times the $1,809 reported in 2019. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,314in general payments, 2019–2025

Across 250 payments — averaging $49.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$3K
  • Acclarent, Inc$3K
  • Jazz Pharmaceuticals Inc.$1K
  • Inspire Medical Systems, Inc.$1K
  • Medical Device Business Services, Inc.$458
  • Optinose US, Inc.$442
  • plus $2K from 31 others

What the payments were for

  • Consulting fees$3,00024%
  • Travel & lodging$2,33819%
  • Food & beverage$6,65154%
  • Education$3243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,314 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$244,993
Medicare patients
501
Services billed
3,994

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl259$6,729
Fluticasone Propionate330$4,752
Cevimeline Hcl28$4,022
Ipratropium Bromide120$3,435
Doxepin Hcl11$3,189
Prednisolone Acetate54$2,632
Mupirocin105$2,173
Ofloxacin103$1,975
Eszopiclone16$1,705
Omeprazole118$1,492
Fluocinolone Acetonide Oil26$1,002
Cefdinir39$776
Montelukast Sodium77$675
Pantoprazole Sodium65$578
Doxycycline Hyclate48$433

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →